Bacteriostatic Water 30mL Canada: Pfizer Hospira USP Diluent
Pfizer Hospira Bacteriostatic Water for Injection USP 30mL is a sterile, multi-dose pharmaceutical diluent supplied in a 30 mL vial. Hospira labeling identifies the 30 mL presentation as Bacteriostatic Water for Injection, USP containing 0.9% benzyl alcohol (9 mg/mL) added as a bacteriostatic preservative. For Canadian product identity, Health Canada lists Bacteriostatic Water for Injection USP as a marketed 30 mL product from Pfizer Canada ULC under DIN 00038202. Tier One lists this branded item for research and laboratory procurement only and does not provide dosing, injection, administration or reconstitution instructions.
Quick Product Profile
| Product |
Bacteriostatic Water for Injection, USP |
| Brand / manufacturer context |
Pfizer / Hospira |
| Volume |
30 mL |
| Container |
Multi-dose vial |
| Preservative |
0.9% benzyl alcohol (9 mg/mL) per Hospira labeling |
| Canadian regulatory reference |
Health Canada DIN 00038202 — Pfizer Canada ULC — Marketed |
| Tier One listing purpose |
Laboratory and research procurement only |
What Is Bacteriostatic Water?
Bacteriostatic water is sterile water formulated with a bacteriostatic preservative. In the Hospira 30 mL presentation, benzyl alcohol is present at 9 mg/mL, equivalent to 0.9%. The preservative distinguishes this product from preservative-free sterile water and supports the manufacturer’s multi-dose container classification. The term bacteriostatic refers to the preservative system; it should not be interpreted as a claim that ordinary laboratory handling, storage controls or aseptic technique are unnecessary.
Pfizer and Hospira Product Identity
Researchers and procurement teams commonly search for this item using both Pfizer bacteriostatic water and Hospira bacteriostatic water. Official records reflect that naming history: the current Canadian Drug Product Database lists Pfizer Canada ULC for the 30 mL product, while the official U.S. drug label identifies Hospira, Inc. on the 30 mL multi-dose presentation. Because packaging and regulatory identifiers can differ by market, buyers should rely on the label and lot information on the supplied vial rather than assuming a U.S. identifier applies to a Canadian presentation.
Canadian Regulatory and Laboratory Context
Health Canada currently records Bacteriostatic Water for Injection USP, 30 mL, as a marketed human drug product from Pfizer Canada ULC. That regulated manufacturer status is separate from Tier One’s own sales policy. Tier One does not position this listing as a treatment product or provide clinical-use guidance. Within the Tier One catalog, the item is offered as a branded laboratory and research supply. Purchasers are responsible for ensuring that acquisition, possession and use comply with the rules applicable to their institution and jurisdiction.
Storage and Product Handling
Hospira labeling for the 30 mL presentation specifies storage at 20°C to 25°C under USP controlled room-temperature conditions. Researchers should retain the original manufacturer label, lot and expiry information and follow the packaged product’s official storage requirements. Tier One does not replace manufacturer labeling with separate clinical or administration instructions.
Official Product References
Research FAQ: Pfizer Hospira Bacteriostatic Water 30mL
What preservative is in Hospira Bacteriostatic Water 30mL?
The official Hospira label for the 30 mL multi-dose presentation states that it contains 0.9% benzyl alcohol, equivalent to 9 mg/mL, added as a bacteriostatic preservative.
Is Pfizer Bacteriostatic Water 30mL listed in Canada?
Yes. Health Canada lists Bacteriostatic Water for Injection USP as a marketed 30 mL product from Pfizer Canada ULC under DIN 00038202.
Is bacteriostatic water the same as preservative-free sterile water?
No. The defining difference in this Hospira presentation is the addition of benzyl alcohol as a bacteriostatic preservative and its multi-dose packaging. Preservative-free sterile water is a different product category.
Why does the product use both the Pfizer and Hospira names?
Canadian regulatory records identify Pfizer Canada ULC, while Hospira appears on official labeling for the 30 mL presentation in the United States. Using both names helps researchers identify the branded product without assuming that packaging or regulatory numbers are identical across markets.
How should the 30 mL vial be stored?
Hospira labeling specifies controlled room-temperature storage at 20°C to 25°C. The label, lot and expiry information on the actual supplied vial should remain the primary handling reference.
Does Tier One provide injection or reconstitution directions?
No. Tier One supplies research materials and laboratory supplies and does not provide personalized dosing, injection, administration or reconstitution instructions. For research purposes only. Not for human or veterinary use through Tier One.
